| [1] |
McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia[J].J Urol, 2011, 185(5): 1793-1803.
|
| [2] |
Sohn JH, Choi YS, Kim SJ, et al. Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants[J]. Korean J Urol, 2011, 52(3): 178-183.
|
| [3] |
DeMeritt JS, Elmasri FF, Esposito MP, et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization[J]. J Vasc Interv Radiol, 2000, 11(6): 767-770.
|
| [4] |
Carnevale FC, Antunes AA, da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients[J]. Cardiovasc Intervent Radiol, 2010, 33(2): 355-361.
|
| [5] |
方主亭, 颜志平, 唐仪, 等. 前列腺动脉栓塞治疗犬前列腺增生的初步研究[J]. 中华放射学杂志, 2013(6): 551-554.
|
| [6] |
de Assis AM, Moreira AM, de Paula Rodrigues VC, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification[J]. Cardiovasc Intervent Radiol, 2015, 38(4): 855-861.
|
| [7] |
Torres D, Costa NV, Pisco J, et al. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm embospheres[J]. J Vasc Interv Radiol, 2019, 30(5): 638-644.
|
| [8] |
Wang MQ, Zhang JL, Xin HN, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-μm plus 100-μm polyvinyl alcohol (PVA) particles versus 100-μm PVA particles alone: a prospective randomized trial[J]. J Vasc Interv Radiol, 2018, 29(12): 1694-1702.
|
| [9] |
Carnevale FC, Moreira AM, de Assis AM, et al. Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience[J]. Radiology, 2020, 296(2): 444-451.
|
| [10] |
Bilhim T, Pisco J, Pereira JA, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia[J]. Radiology, 2016, 281(1): 289-300.
|
| [11] |
Pisco JM, Bilhim T, Costa NV, et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia[J]. Eur Urol, 2020, 77(3): 354-362.
|
| [12] |
Tang Y, Zhang JH, Zhu YB, et al. Effect of superselective prostatic artery embolization on benign prostatic hyperplasia[J]. Abdom Radiol (NY), 2021, 46(4): 1726-1736.
|
| [13] |
Ayyagari R, Powell T, Staib L, et al. Prostatic artery embolization using 100-300-μm trisacryl gelatin microspheres to treat lower urinary tract symptoms attributable to benign prostatic hyperplasia: a single-center outcomes analysis with medium-term follow-up[J]. J Vasc Interv Radiol, 2020, 31(1): 99-107.
|
| [14] |
de Assis AM, Maciel MS, Moreira AM, et al. Prostate zonal volumetry as a predictor of clinical outcomes for prostate artery embolization[J]. Cardiovasc Intervent Radiol, 2017, 40(2):245-251.
|
| [15] |
吴少杰, 蔡森林, 唐仪, 等. 介入栓塞与经尿道电切术治疗高龄良性前列腺增生症临床对比[J]. 介入放射学杂志, 2019, (2): 179-183.
|
| [16] |
Lin YT, Pereira H, Pellerin O, et al. Four-year impact of voiding and storage symptoms in patients with benign prostatic hyperplasia treated with prostatic artery embolization[J]. J Vasc Interv Radiol, 2020, 31(9): 1460-1466.
|
| [17] |
Sun F, Lucas-Cava V, Sánchez-Margallo FM. Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review[J]. Transl Androl Urol, 2020, 9(4): 1754-1768.
|
| [18] |
Kozlowski R, Kershen RT, Siroky MB, et al. Chronic ischemia alters prostate structure and reactivity in rabbits[J]. J Urol, 2001, 165(3): 1019-1026.
|
| [19] |
Abt D, Müllhaupt G, Mordasini L, et al. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial[J]. BJU Int, 2019, 124(1):134-144.
|
| [20] |
Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia[J]. AJR Am J Roentgenol, 2014, 203(4): 813-821.
|
| [21] |
Shin SH, Kim JW, Kim JW, et al. Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction[J]. Korean J Urol, 2013, 54(6): 369-372.
|
| [22] |
Hirayama K, Masui K, Hamada A, et al. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention[J]. Urology, 2015, 86(3):565-569.
|
| [23] |
Jeong CW, Lee S, Oh JJ, et al. Quantification of median lobe protrusion and its impact on the base surgical margin status during robot-assisted laparoscopic prostatectomy[J]. World J Urol, 2014, 32(2): 419-423.
|
| [24] |
Little MW, Boardman P, Macdonald AC, et al. Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched Case-Control Study[J]. Cardiovasc Intervent Radiol, 2017, 40(5): 682-689.
|
| [25] |
Lin YT, Amouyal G, Correas JM, et al. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE[J]. Eur Radiol, 2016, 26(10): 3466-3473.
|